Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252520 | SCV000314111 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000252520 | SCV000522623 | benign | not specified | 2016-01-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001812734 | SCV001159588 | benign | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001512550 | SCV001719990 | benign | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001812734 | SCV005294699 | benign | not provided | criteria provided, single submitter | not provided |